The WACC of Horizon Therapeutics PLC (HZNP) is 7.0%.
| Range | Selected | |
| Cost of equity | 6.00% - 8.40% | 7.20% |
| Tax rate | 6.50% - 11.50% | 9.00% |
| Cost of debt | 4.90% - 5.30% | 5.10% |
| WACC | 5.9% - 8.1% | 7.0% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.47 | 0.63 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.00% | 8.40% |
| Tax rate | 6.50% | 11.50% |
| Debt/Equity ratio | 0.1 | 0.1 |
| Cost of debt | 4.90% | 5.30% |
| After-tax WACC | 5.9% | 8.1% |
| Selected WACC | 7.0% | |